Understand the complete disease landscape and size global markets with real-world data. DRG’s Epidemiology cover 140+ diseases, 40+ countries, 3,400 patient segments, including extensive insights of oncology populations by stage, line of therapy, and biomarker. Learn more about DRG Epidemiology here.

The poster below was presented by DRG Epidemiologists Giegerich E, Ayodele O, John A, Hughes M, van der Pluijm W, Gezmu T at International Society of Pharmacoeconomics and Outcomes Research (ISPOR), 23rd Annual International Meeting on Estimating the Global Diagnosed Prevalence of Crohn’s Disease 2017-2027.




Mainland China’s anticipated biosimilar boom – potential and key drivers of the market

View Now